Canada Pension Plan Investment Board
RXRX icon

Canada Pension Plan Investment Board’s Recursion Pharmaceuticals RXRX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Buy
+31,300
New +$104K ﹤0.01% 1661
2026
Q1 		– Sell
-98,400
Closed -$402K – 1969
2025
Q4 		$402K Buy
+98,400
New +$487K ﹤0.01% 1390

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Canada Pension Plan Investment Board's RXRX Position: Q2 2026 in Review

Canada Pension Plan Investment Board opened a new position in Recursion Pharmaceuticals (RXRX) in Q2 2026: 31,300 shares worth $115K. The stake represents ﹤0.01% of the portfolio and ranks #1661 among its holdings. This is a return to the name: Canada Pension Plan Investment Board previously reported a position in RXRX as recently as Q4 2025.

Canada Pension Plan Investment Board first reported a position in RXRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $402K in Q4 2025. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Canada Pension Plan Investment Board held 31,300 shares of Recursion Pharmaceuticals worth $115K as of Q2 2026.
  • Recursion Pharmaceuticals was a new Canada Pension Plan Investment Board position in Q2 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1661 holding.
  • Canada Pension Plan Investment Board first reported a position in Recursion Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Canada Pension Plan Investment Board's Recursion Pharmaceuticals position peaked at $402K in Q4 2025.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.